Michael Bayewitch, Director, S&E, Biologics at Teva Pharmaceuticals USA
Teva Pharmaceuticals USA Logo

Michael Bayewitch


Director, S&E, Biologics
Teva Pharmaceuticals USA

Check out the incredible speaker line-up to see who will be joining Michael.

Download The Latest Agenda

Innovative Dealmaking

Friday, June 10th, 2016


16:25 Panel Discussion | Key Strategies for Success in Early Stage Partnering

• What data are buyers looking for?
• How can you best differentiate your product in a crowded space?
• With pharma and VCs taking a greater interest in early stage opportunities, what can biotech and academic institutions do to be most competitive?